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ABSTRACT 
 
Using a recirculation procedure to perfuse anaesthetised rat jejunum, E. coli STa enterotoxin can 
be shown to inhibit net fluid absorption profoundly, while not causing net fluid secretion, provided 
fluid measurement is by mass or volume. This observation contradicts many reports of STa 
causing secretion, implying that the recovered volume technique in the anaesthetised animal over 
a period of some hours cannot detect secretion because of conjectured or unspecified flaws. 
Experiments are presented here confirming the viability of the perfusion protocol used in this 
laboratory but also demonstrate that if secretion were to be occurring, the recovered volume 
protocol would detect it. It will only return a negative finding, if secretion does not occur. To this 
end, the effect of two secretory toxins on intestinal fluid movement in a closed loop preparation 
Original Research Article 
 
 
 
 
 
Lucas et al.; JAMMR, 28(2): 1-11, 2018; Article no.JAMMR.44118 
 
 
 
2 
 
were studied to demonstrate that the anaesthetic, intestinal preparation or perfusion duration did 
not hinder the demonstration of net secretion when the intestine was exposed to E. coli LT and C. 
difficile toxin A.. It is evident that STa itself only reduces net absorption but can appear to be 
secretory if driving forces such as luminal osmotic pressure or capillary hydrostatic pressure 
through vasodilatation are introduced, as was likely to have occurred with pithing and theophylline. 
The recognition that STa is a non-secretory enterotoxin necessarily falsifies several alternative 
methods that claim to demonstrate secretion. Since STa is not secretory many other substances 
identified by these methods need also not be secretory and alternative explanations must be found 
to explain their action. The importance of recognising that action on the small intestine cannot be 
attributed to a secretory mechanism within the enterocyte adds further weight to the concept that 
where net secretion does occur, the likely mechanism for it is a combination of increased 
vasodilatation together with increased hydraulic conductivity. 
 
 
Keywords: Intestine; secretion; diarrhoeal disease; E. coli STa; enterotoxin; enterocyte. 
 
1. INTRODUCTION 
 
Almost a half century ago, the means by which 
large volumes of fluid entered the small intestine 
in cholera was proposed [1,2] to be secretory 
processes residing within the villous enterocyte 
(epithelial) cells. This view revived a neglected 
hypothesis from an earlier century [3a, b], 
namely that the epithelial layer caused secretion, 
since it was often intact in severe cholera, yet 
fluid secretion persisted. The attribution, at that 
time, of secretion solely to the enterocytes was a 
critical non-sequitur since the possibility of it 
originating from the sub-epithelial space and by-
passing the enterocytes was not considered. A 
consequence this misattribution was that later 
research concentrated almost exclusively on 
enterocyte mediated secretion, resulting in the 
concept of luminally directed chloride ion [4,5] 
driving fluid secretion. Most subsequent research 
involved elucidating the molecular details of this 
process and continues to do so [6]. Other 
directions were investigated that either directly or 
obliquely [7,8] indicated the paracellular pathway 
as a route for severe fluid loss but the dominant 
paradigm remained unchallenged. It seemed 
self-evidently true, given the large extent of 
apparently confirmatory data, most not involving 
measurements of mass transport. More recently, 
a challenge to the validity of the paradigm has 
arisen solely because of the properties of the 
heat stable (STa) form of E. coli enterotoxin, 
involving fluid recovery.  
 
This anti-absorptive toxin meets all in vitro 
criteria for being secretory, i.e. increased short 
circuit current [9,10] and luminally directed 
chloride ion flux increases [11] but fails to cause 
fluid secretion in vivo in the perfused small 
intestinal loop [12]. If STa is not secretory as 
measured by mass transport of fluid, then there 
must be doubt about the prevailing in vitro 
methods used to demonstrate secretion; the 
events attributed to secretion are not secretory 
and undermine evidence for the enterocyte 
model of secretion, which becomes a doctrine 
without proof [13]. An attempt at reconciliation is 
that STa is indeed not secretory but is an 
aberrant enterotoxin for reasons that are unclear; 
the lack of secretion is a distracting, minor 
feature of intestinal pathophysiology, potentially 
eventually explicable within the present 
enterocyte based paradigm. A more robust 
defence of the paradigm is that contradictory 
findings originate from one laboratory only 
[12,14-18] and could represent merely the failure 
in one laboratory to demonstrate the known fact 
of secretion. The error must arise through 
inadequate maintenance of blood pressure, a 
poor perfusion regime that prevents secretion 
from manifesting itself or a combination of these 
and other unrealised factors. 
 
To allay this last critique, small intestine was 
exposed in vivo to E. coli LT, C. difficile toxin A 
and osmotic challenge, all known to cause 
secretion. The normal protocol for E. coli STa 
experiments was adapted to the closed, 
unperfused loop procedure that demonstrates 
net secretion with C. difficile enterotoxin [19]. 
STa in combination with a second circumstance 
such as added theophylline, a luminal osmotic 
load or pithing was also undertaken to achieve 
net fluid secretion. STa enterotoxin was re-
confirmed as an anti-absorptive but not a 
secretory toxin.  The lack of secretion after STa 
exposure in a preparation that can detect 
secretion, were it to occur, must call into question 
some currently preferred methods for studying 
secretion and further challenge the concept of 
enterocyte secretion being the root cause 
disorder of secretory diarrhoeal disease. 
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2. METHODS AND MATERIALS 
 
2.1 In vivo Perfusion Procedures 
 
All experiments complied with UK (1986) animal 
research legislation. Absorption of fluid in vivo 
from perfused jejunal loops was measured by a 
recirculation procedure [20], described in detail 
elsewhere [12,14], using a fluid recovery method 
[21]. Adult Sprague-Dawley female rats were 
anaesthetised (70 mg/Kg i. p.) with sodium 
pentobarbitone (Sagatal) and tracheotomised. 
Isolated loops were perfused in the distal 
direction at 1.8 ml/ min by a peristaltic pump from 
a reservoir maintained at 37ºC.  The entry 
cannula was of 2 mm internal diameter, with a 4 
mm exit cannula, as wide as possible to prevent 
any increases in luminal pressure as measured 
by manometer, while still allowing cannulation. 
After three hours, recirculation was stopped with 
all perfusate collecting in the reservoir. The loop 
was excised and remaining perfusate was 
drained by gravity into the reservoir, assisted by 
further flushing with air by syringe. Recovered 
volume was measured to the nearest 0.1ml, this 
representing 0.4% of a 25 ml volume of 
perfusate. The perfusate was a solution of 100 
mM sodium bicarbonate and 54 mM sodium 
chloride, unless otherwise stated. Fluid 
absorption, the difference between the initial 
added and final recovered volume, is expressed 
as μl per cm length of intestine per hour, with 
positive values denoting absorption. In a second 
series of perfusion experiments, the effect of 
combination of STa perfusion with an additional 
perturbing substance was investigated. STa 
luminal perfusion was supplemented by luminal 
theophylline and in another set by STa perfusion 
in the pithed rat preparation. This was done 
because theophylline or other phosphodiesterase 
inhibitors are sometimes used to supplement 
STa action, having assumed that both factors act 
through the same pathway and elevate cGMP 
concentrations within the enterocyte.  Similarly, 
the pithed animal does not require long term 
anaesthesia and also can often show secretion 
that can be enhanced by luminal STa perfusion, 
again with the implicit assumption that both are 
acting on the same enterocyte secretion 
mechanism. 
 
2.2 In situ Loop Preparation 
 
Some experiments were done using in situ filled 
but unperfused loops to confirm that net fluid 
secretion caused by enterotoxins could be 
detected using the same duration and 
anaesthetic regime. Initially, fluid movement in 
vivo was measured using in situ closed (i.e. non-
perfused) loops, using a protocol that had 
previously been able to demonstrate Clostridium 
difficile toxin A mediated secretion [19], in 
animals allowed to recover from short term 
anaesthesia.  
 
The present in situ loop experiments were done 
under anaesthesia for the duration of the 
experiment, without recovery. Three loops were 
formed, approximately 10 cm past the ligament 
of Treitz. Two 10 cm length jejunal loops were 
created, separated by a 5 cm empty loop that 
prevented the transfer of content between loops. 
Test and control loops was flushed with isotonic 
saline to remove debris and then with air to expel 
residual fluid. To test the effectiveness of an 
enterotoxin, one ml of solution containing either 
saline or saline plus enterotoxin was introduced 
through a cannula and the loop end was tied off. 
The introduced amount was measured by 
weighing a syringe before and after fluid 
introduction. Enterotoxins were assigned 
randomly. Initially, the infusate was 20 mM 
ethanolamine and 0.2 M NaCl adjusted to pH 7.5 
[19], duplicating a protocol that had originally 
shown secretion with C. difficile toxin A. After this 
initial duplication of results using a successful 
protocol, the loop infusate was changed to 
isotonic saline with or without toxin to confirm 
that C. difficile toxin A was secretory even in the 
absence of an inadvertently imposed isosmotic 
gradient.  
 
Unless otherwise stated, loops were left for two 
hours, excised and weighed uncut, then cut but 
with luminal solution recovered by gravity 
drainage and weighed. At the end of the 
experiment, the animals were humanely killed 
under terminal anaesthesia. Fluid accumulation 
was expressed as in the Torres protocol [19] as 
mean ratio of uncut loop weight to loop length; 
the control ratio was subtracted from the toxin 
ratio, giving a single difference value for each 
pair of loops. Ratios were also individually 
considered. In addition to this, absorption was 
measured by direct reference to the recovered 
volume that was weighed at the end of the 
experiment. Fluid movement estimates were 
therefore based both on explicit volume 
measurements derived from recovered volume 
which is the preferred method in this laboratory 
and on implied volumes derived from differences 
in loop weight before and after drainage. It was 
thought important to do this to check for any 
systematic difference or difficulties with the 
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closed loop method of assessing fluid absorption 
compared with the open perfused loop method 
used routinely [12,14 -16] in this laboratory. 
   
The length of the loop was measured after laying 
out the excised loop without stretch, allowing 
fluid absorption to be expressed as μl per cm 
length of intestine per hour. Excised loops were 
weighed and also dried to constant weight in an 
oven at 100ºC, allowing fluid uptake also to be 
standardised per milligram dry weight and per 
gram wet weight. These were calculated but only 
fluid flows per cm length are presented here as 
changing the standardisation variable did not 
alter any statistical inferences.  
 
2.3 Blood Pressure Experiments 
 
Arterial blood pressure was measured via a 
carotid cannula (Portex, ‘pink’ o. d. 0.9 mm) 
using a Harvard pressure transducer, coupled to 
a Toshiba lap-top computer and recorded using 
Spike 2 for data capture via the CED 1401 
interface (Cambridge Instruments, Cambs, UK). 
Heart rate and respiration frequency (from the 
Traube-Hering waves) were also measured from 
the blood pressure record. 
 
2.4 Administration of Chemicals and 
Enterotoxins  
 
Synthetic STa (Sigma) was given at a 
concentration of 80 ng/ml of perfusate. STa from 
P16 E. coli was given as a dose in saline to 
equal this, as was LT from E49 E. coli. 
Clostridium difficile toxin A was added to loops at 
5.0 μg protein per 1 ml loop.  
 
2.5 Source of Chemicals 
 
E. coli STa and other chemicals were purchased 
from Sigma Chemical Co (Poole, UK), Sagatal 
(sodium pentobarbitone) from Rhone Merieux Ltd 
(Harrow, UK). For  closed loop experiments, STa 
from a P16 strain of E. coli was used (gift of Dr. 
M. Burgess, Beecham Pharmaceuticals, UK), LT 
from an E49 strain of E. coli (gift from Houghton 
Poultry Research Institute, Huntingdon, UK) and 
C. difficile toxin A from Professor R. Aitken, 
University of Glasgow. 
 
2.6 Statistical Analysis of Data 
 
Results are given as the mean and standard 
error of the mean, with the number of 
experiments, equal to the number of animals in 
parenthesis. Implementation of statistical 
analysis was done using BMDP [22]. 
Comparison of means was by paired and 
unpaired “Student’s” ‘t’-values with Dunnett’s [23] 
correction for any multiple comparisons. In 
addition, significant differences for proportions or 
frequencies were calculated by Fisher’s exact 
test with Yates’ correction for small numbers and 
confirmed by testing the odds ratio (Sokal & 
Rohlf, 24). 
 
3. RESULTS 
 
3.1 Data and Observations on Methods of 
Measuring Intestinal Fluid Transport 
in vivo by the Recovered Volume 
Protocol 
 
Fluid recovery for measuring fluid transport, 
involving three hours perfusion in vivo, was 
preferred to the alternative but widespread 
method of calculation of volume using assumedly 
unabsorbable marker substances. These are 
now known [25] to introduce gross errors as loss 
of label by absorption gives false positive 
indications of secretion both in short duration 
experiments and when low absorption rates 
occur. A critique of the fluid recovery protocol 
used in this laboratory is that the E coli STa 
induced intestinal secretion that assumedly 
should occur, cannot be shown. This lack can be 
attributed to a lengthy perfusion period compared 
with most in vitro procedures and other 
accessory conditions, including perfusate 
content, poor maintenance of blood pressure, 
differing responses between male and female 
rats, paradoxical responses to anaesthesia or 
simply just an unspecifiable inability to respond 
to secretory stimuli. Since all observations on the 
failure to secrete after exposure to STa 
enterotoxin seemed to arise only when the fluid 
recovery technique was used and that in one 
laboratory only, this could be taken to imply a 
technique mediated failure to show secretion 
rather than an absence per se of secretion. 
Consequently, it was necessary to consider 
these concerns. 
 
Failure to maintain an adequate blood pressure 
and heart rate does not occur in the chosen 
protocol. An initial heart rate of 394 ± 22 (5) 
beats per minute (Table 1) did not vary 
throughout perfusion and ended at 379 ± 4.6 (5) 
beats per minute. Mean arterial blood pressure of 
132 ± 9.0 (5) mmHg at the onset, remained 
steady and ended at 125 ± 4.0 (5) mmHg. Falls 
in pressure were inducible by i.v. perfusion with 
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2.8 mg/Kg/hr cromakalim, from 108 ± 11.7 (5) to 
62.4 ± 7.0 (5) mmHg. Hence, while barbiturate 
anaesthetised animals did not suffer from 
deleterious blood pressure changes that might 
have prejudiced the detection of secretion, falls 
in blood pressure were detectible when these 
were deliberately induced. Sex of the animals 
was also not relevant to maintenance of blood 
pressure since initial blood pressure in three 
female animals of comparable weight to the 
males was 109.3 ± 12.2 (3) mmHg and rose to 
124.7± 4.9 (3) mmHg by the end of the 
recirculation period. 
 
Intravenous infusion of glucose-containing saline 
is sometimes advocated as mandatory for 
maintenance of adequate blood pressure. In the 
absence of intravenous fluid infusion, blood 
pressure is well maintained in the present 
protocol. In two male animals, given i.v. isotonic 
saline at 1ml/hour, blood pressure did not differ 
(Table 1) from unsupplemented animals. 
Perfusate bicarbonate anion concentrations 
resembling those that arise in the lumen during 
pancreatic secretion, promote fluid absorption 
[26]. Intestinal fluid uptake of 5 - 6 mls over a 
three hour period already approximates 
commonly used hourly rates of i.v. fluid infusion. 
Hence, additional i.v. infusion will overhydrate 
and expand the plasma volume which is known 
to predispose to fluid secretion.  Glucose addition 
to the intestinal perfusate might be deemed to be 
desirable to counteract purportedly inadequate 
tissue nutrition during a three hour perfusion but 
plasma glucose concentrations did not decline 
over the experimental period. Inclusion of 
glucose in any intestinal perfusate would be a 
severe complicating factor as it would stimulate 
fluid absorption despite the presence of STa and 
may obscure any secretion taking place. The 
experiments would therefore be on intestine 
subjected to enterotoxin but also simultaneously 
to a form of oral rehydration solution, as occurs 
with most, if not all, in vitro and some in vivo 
experiments.  
 
3.2 Detection of Secretory Action of 
Toxins and Circumstances Known to 
Cause Net Secretion of Fluid in the 
Small Intestine 
 
With E. coli STa in the absence of any adverse 
osmotic gradient (Fig. 1), STa, as expected, 
reduced absorption in the bicarbonate perfusate 
from 84.4 + 8.4 (4) μl/cm/hr to 11.4 + 6.6 (4) 
ul/cm/hr, not significantly different from zero net 
absorption but not indicating  net secretion. With 
isotonic saline, a lesser rate of normal absorption 
of 51.5 + 5.2 (5) μl/cm/hr was reduced 
significantly (p < 0.01) to a value of 9.4 + 10.4 (5) 
μl/cm/hr by STa, not significantly different from 
zero net fluid absorption. Where a hypertonic 
perfusate was additionally recirculated as in the 
Torres protocol [19], net fluid absorption was 
25.3 + 9.4 (5) μl/cm/hr, becoming net secretory 
through the combination of STa exposure and an 
adverse osmotic gradient to - 34.4 + 3.6 (5) 
μl/cm/hr, significantly different from normal 
absorption (p < 0.01) but also significantly (p < 
0.01) secretory (Table 2). Exposure of the loop to 
LT enterotoxin from E. coli reduced net 
absorption in saline significantly (p < 0.01) from 
47.9 + 4.4 (9) μl /hr/cm to -27.1 + 11.0 (9) 
μl/cm/hr, which was a significantly (p < 0.05) net 
secretory value. Clostridium difficile toxin A 
changed net fluid absorption of 35.0 + 1.7 (5) 
μl/cm/hr to net fluid secretion of -10.3 + 4.3 (11) 
ul/cm/hr into the lumen. Every loop exposed to C. 
difficile toxin A had a final loop weight that 
exceeded the initial injected weight and also had
 
Table 1. Mean arterial blood pressure and heart rate at the start and end of a three hour 
perfusion period in normal male, normal female rats and i.v. infused normal male rats 
undergoing Sagatal (70 mg/Kg body weight) anaesthesia in vivo 
 
Mean arterial 
Blood pressure 
(mmHg) 
Heart rate 
beats per minute 
(bpm) 
Experimental circumstances 
  Without i.v. perfusion 
132 ± 9.0 (5) 394 ± 22.0 (5) Male rats, at onset of experiment 
125 ± 4.0 (5) 379 ± 5.0 (5) Male rats, at end of experiment 
109 ± 12.0 (3) 363 ± 16 (3) Female rats, at onset of experiment 
125 ± 5.0 (3) 375 ± 15.0 (5) Female rats, at end of experiment 
  With i.v. perfusion 
134 (2) 400 (2) Male rats, at onset of experiment 
105 (2) 355 (2) Male rats, at end of experiment 
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a higher recoverable volume, thus demonstrating 
that net fluid secretion can be detected if an 
enterotoxin is capable of causing net fluid 
secretion. It could also be detected using a            
non-secretory toxin if an adverse osmotic 
gradient was also present. Hence, where 
circumstances would allow secretion to be occur, 
this could be observed in the barbiturate 
anaesthetised animal preparation protocol used 
in this laboratory. 
 
3.3 Joint Exposure to Luminal STa 
Enterotoxin and a Second Perturbing 
Factor 
 
In the case of theophylline perfusion, the results 
are self-evident in that STa reduces net fluid 
absorption (Table 2) but does not lead to net 
secretion. Only when theophylline is additionally 
perfused is there net secretion that is significantly 
different (p< 0.01) from zero net fluid absorption, 
all six experiments leading to more fluid 
recovered than was added to the reservoir. 
 
In a pithed group of animals, a combination of 
STa and pithing led to net fluid secretion that was 
statistically significant when a one sided test was 
used i.e. that the secretory values were below 
zero net movement. The likelihood that an 
additional, ancillary condition made STa seem 
secretory was tested by considering the numbers 
of secreting and absorbing intestines within each 
experimental series. It should be noted that 
where net secretion occurred in STa treated 
populations, this was a very marginal event that 
small errors in protocol or measurement could 
have induced. To estimate the probability of 
secretion having occurred due to chance, the 
numbers of secreting animals where there was a 
second perturbing factor e.g osmotic load was 
used. The numbers of expected secretory events 
was used, using the least favourable ratio in the 
normal population to test the null hypothesis that 
there was no secretion when STa was co- 
perfused with theophylline, an additional luminal 
burden of osmolarity was imposed or the animals 
were additionally pithed. The least favourable 
ratio for the null hypothesis was used i.e. that for 
the saline and STa group where 1 out of 10 was 
secretory making a likely probability of 0.1. 
 
Using Fisher’s exact probability test for a binary 
event (secretion or absorption) as described 
above, the probability of a second deleterious 
circumstance and STa not causing net secretion 
is very improbable (p < 0.0001). This indicated 
that pithing, additional luminal osmolyte and 
theophylline with STa leads to secretion while 
STa on its own does not. 
 
4. DISCUSSION 
 
A crucial goal of the investigation of secretory 
diarrhoeal disease is to establish the means by 
which fluid is made to enter the small intestine in 
life threatening quantities. Secretory diarrhoea is 
widely held to result from enterotoxins causing 
the epithelial cells (enterocytes) of the villus to 
secrete fluid at abnormally high rates [1, 2].  
Since the inception of this concept, various 
methods have been used to measure secretion, 
including in vitro electrical measurements, in vitro 
radioactive tracer transport measurements or 
flawed in vivo methods [27]. This has led to the 
situation where the proxy methods of detecting 
secretion demonstrate the features associated 
with exposure to enterotoxin, yet the enterotoxin 
does not cause net fluid secretion. A particularly 
clear expression of this dichotomy is the 
undoubted elevation in short-circuit current after 
exposure of small intestinal tissue to heat stable 
E. coli STa [9], whereas no net secretion is found 
in vivo in a perfused loop [12] when luminal fluid 
is physically recovered. A contestable 
explanation for the lack of net fluid secretion after 
STa perfusion of the jejunum of the barbiturate 
anaesthetised rat is that in some way this 
preparation cannot demonstrate secretion after 
STa enterotoxin exposure but would do so if 
other protocols were used - hence, a failure to 
demonstrate secretion is both local and limited to 
laboratories using prolonged recirculation in vivo 
techniques with accompanying barbiturate 
anaesthesia. However, maintenance of blood 
pressure and other vital signs are not 
compromised with barbiturate anaesthesia. The 
suitability of this preparation is also confirmed by 
the fact that net secretion is found when known 
secretory toxins are perfused. STa enterotoxin in 
contrast has the appearance of causing secretion 
when perfusion occurs in the presence of a 
second perturbing circumstance. This 
observation helps to define more clearly how net 
secretion should be measured. 
 
In order to establish whether net fluid secretion 
has occurred, the chosen method should 
unequivocally measure mass transport of fluid. 
This is only achievable by minimising the 
possibilities for volume measurement error and 
introducing no assumptions about the variable 
being measured. These strict criteria rule out the 
use of ‘unabsorbable’ markers because 
calculating volume from concentration change is 
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compromised by their known absorption, which 
violates Fick’s principle [25] and falsely indicates 
secretion. Recirculation of fluid with recovery of 
all volume at the end of the experiment is 
therefore the required in vivo technique. Any 
increase in luminal volume can then only be 
attributed to net secretion. In contrast, any 
method that measures total loop weight 
necessarily measures luminal volume plus 
interstitial and vascular fluid volumes as well [28- 
30]. Weight changes cannot in these 
preparations unequivocally be attributed to fluid 
secretion because vascular events can increase 
interstitial fluid weight, without any fluid entering 
the lumen [31,32]. The weighed loop can be 
seen from any schematic of the apparatus [28– 
29] to include vascular and interstitial fluid 
volume to the total volume; the technique will 
misattribute expansion of the interstitial space 
after vasodilatation to the further, unproven step 
of movement of fluid into the lumen. This may 
explain the many discordant findings between 
the Gothenberg loop preparation and recovery 
protocols when luminal volume alone is 
measured and not total loop weight. Using the 
weighed loop technique, fluid secretion is 
claimed on exposure in vivo to Salmonella 
bacteria [33], to cholera toxin [34] and to E. coli 
STa [35]. In all cases, hexamethonium can 
apparently inhibit the rate of secretion whilst 
atropine cannot. In contrast, using recovered 
luminal volume to assess secretion, Salmonella 
typhimurium infection had little effect on net 
jejunal fluid absorption [36] while the weighed 
loop preparation apparently shows [33] copious 
rates of secretion. Similarly, perfused loop 
preparations showed [14] that STa prevents 
absorption but does not exhibit the apparent 
copious secretion that characterises the weighed 
loop preparation [35]. Neither atropine nor 
hexamethonium affects the secretion caused by 
Clostridium difficile toxin A in the perfused loop 
[7] or the inhibited fluid absorption on perfusion 
with E. coli heat stable STa enterotoxin [18]. In 
contrast, using the weighed loop protocol, 
hexamethonium apparently inhibited the anti-
absorptive actions of STa [30] and the secretory 
actions of C difficile toxin A [37]. An explanation 
for these persistently discrepant findings is that 
the Gothenberg weighed loop preparation 
unavoidably also measures fluid entry into the 
interstitial space from the vasculature as well as 
any expansion of intravascular volume.  As a 
consequence, many pharmacological 
interventions that are claimed to be anti-
secretory may be vascular events leading to the 
erroneous conclusion that fluid secretion into the 
lumen has been altered.  
 
In contrast, the recovered luminal volume 
protocol does not have this defect and should be 
the preferred procedure for detection of net fluid 
secretion, for which phenobarbitone is known to 
be the preferred anaesthetic [38]. The failure to 
detect widely expected secretion after STa 
exposure can be shown not to be due to failure 
of technique in this laboratory or inadequate 
maintenance of blood pressure under 
anaesthesia since net fluid secretion can be 
detected when a loop is exposed to E. coli LT,
 
Table 2. The effect of E. coli STa toxin plus a second perturbing factor (10 mM luminal 
theophylline, pithing or a luminal osmotic load) on jejunal fluid absorption in vivo in 
anaesthetised rats. 
 
Perfusate Control Secretion to  Plus STa Secretion to 
absorption 
ratio 
absorption 
ratio 
150 mM bicarbonate 94.9 + 8.0 (21) 0/21 18.8 + 3.2 (10) 
d, g
 0/10 
100 mM bicarbonate 94.5 + 5.7 (19) 0/19 24.2 + 5.1 (17) d, f 2/17 
100 mM bicarbonate plus 47.2 + 11.3 (6) 
b
 0/6 -25.8 +4.0 (6) 
d, g
 6/0 
h
 
10 mM theophylline     
154 mM saline 59.7 + 6.4 (10) 0/10 25.2 + 5.3 (10) 
d, f
 1/9 
154 mM saline 18.2 + 4.4 (9) 
c
 0/9 -9.1 + 4.8 (9) 
d, e
 7/2 
h
 
plus pithing     
154 mM saline 25.3 + 9.4 (5) 
a
 0/5 -34.4 + 3.6 (5) 
d, g
 5/0 
h
 
plus 140 milliosmoles     
luminal osmotic load     
Symbols: a = p<0.02; b = p<0.01; c = p<0.001, for comparison with appropriate control mean; first symbol in STa 
column d = p<0.001 for comparison of STa v control; second symbol in STa column, e = p<0.05;  f = p<0.01; g = 
p<0.001 STa mean v zero net absorption Symbol h = p< 0.001 for exact probability of differences in secretion to 
absorption numbers arising by chance. 
Fig. 1. The effect of A) E. coli STa in high bicarbonate (100 mM) perfusate, B) 
saline, C) E. coli LT in saline and D) 
Jejunal fluid absorption or secretion assessed by the inoculated non
anaesthetised rats. Statistical significance by pai
for toxin values compared with zero net absorption.
 
Clostridium difficile toxin A or adverse osmotic 
pressure gradients. In this respect, 
an important enterotoxin for investigating 
whether a process is secretory or not since STa 
can almost completely suppress fluid absorption, 
thus allowing the testing of whether a second 
procedure or enterotoxin is genuinely secretory.
 
E. coli STa is not a secretory toxin but it can 
appear secretory when STa is used in 
conjunction with an agent such as theophylline 
that has pressor actions. Similarly, 
can misleadingly be deduced to be secretory 
when perfused in a pithed animal. Pithing 
removes spinal nerve control and it is likely that 
sympathetic vasoconstriction is absent. This 
makes it likelier that pithing and theophylline are 
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Clostridium difficile toxin A in saline on jejunal fluid 
absorption (μl/cm/hr). 
-perfused loop technique in vivo in 
red ‘t’-test, * = p < 0.01 for all control v toxin means, ** = p< 0.05 
 
E. coli STa is 
 
E. coli STa 
secretory in their own right since they are 
associated with reduced arterial blood pressure 
and hence increased capillary pressure, making 
the jejunum secretory because of altered Starling 
forces [17]. Secretion under these circumstances 
would be opposed by normal absorption but 
would become very evident when fluid absorption 
was inhibited by STa. Although it is poss
the addition of theophylline or iso
xanthine could enhance enterocyte second 
messenger concentrations or turnover, their 
actions would not only affect the enterocytes 
since they also have known actions on smooth 
muscle. This would explain why some 
studies seem to show net secretion in the 
presence of STa but only when IBMX is added to 
the perfusate [39]. 
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The lack of genuine secretion after STa 
exposure, when measured  by the simplest 
method of collecting fluid, contrasts starkly with 
an alleged demonstration of secretion using 
other methods: weighed loop measurements 
aggregate interstitial with luminal volume change; 
net flux measurements showing increased 
serosal to mucosal chloride ion fluxes must also 
be discounted since the mathematics of the three 
compartment model  as applied to the Ussing 
chamber do not permit the simple conclusion that 
net flux is the result of two independent 
‘unidirectional’ fluxes [40]; short-circuit current 
elevations have been widely adopted as a 
reliable method of  measuring net fluid secretion 
yet STa will elevate short-circuit current whilst 
not causing secretion; markers such as 
polyethylene glycol can indicate secretion yet the 
known absorption even of small amounts of 
marker compromises calculation of volume from 
concentration since loss of label would be 
wrongly attributed to net secretion [41]. 
 
5. CONCLUSION 
 
The difficulties with misattribution of cessation of 
absorption to enterocyte secretory processes, as 
arises when the prevailing methods detailed 
above are used, are twofold; i) important 
observations can be misinterpreted and ii) 
epiphenomena such as elevations in short             
circuit current are studied almost to the       
exclusion of fluid movement and buttress a false 
model of how fluid secretion is achieved. Both 
these aspects derive from an erroneous             
model of fluid secretion stemming from the 
enterocytes, the persistence of which paradigm 
continues to disappoint [6] and also to prevent 
the discovery of effective anti-diarrhoeal 
medications. 
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